CPH 0.00% 0.9¢ creso pharma limited

Ann: Mernova reaches significant market share milestone, page-20

  1. 4,259 Posts.
    lightbulb Created with Sketch. 685
    Totally agree with this. There is no doubt that Mernova is generating good revenue, but how close is it to profitability from a lifecycle cost perspective (including initial capital costs of construction and fit out etc)? I reckon they are miles away, which is why they never report on it...
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.